Rodriguez-Merchan Emerito Carlos, Yohannan Binoy, Escobar Miguel A
Department of Orthopaedic Surgery, La Paz University Hospital-IdiPaz, Madrid, Spain.
Division of Hematology/Oncology, University of Texas Health Science Center at Houston, Houston, USA.
Haemophilia. 2025 May;31(3):373-390. doi: 10.1111/hae.70036. Epub 2025 Mar 23.
Acute compartment syndrome (ACS) is a surgical emergency defined as an increase in intramuscular pressure within a compartment that compromises capillary perfusion and threatens the survival of compartment tissues. A sustained increase in compartment pressure causes irreversible necrosis of nerves and muscles, leading to permanent damage.
To conduct a narrative review of the literature on the diagnosis and treatment of ACS in persons with congenital and acquired haemophilia (PwH) METHODS: An English-language literature search for articles published before 28 February 2024 was performed in PubMed (MEDLINE) and the Cochrane Library using "haemophilia and compartment syndrome" as keywords.
We found 77 articles in PubMed (of which 19 were eliminated as not strictly related to the topic) and 1 in the Cochrane Library (which was repeated in PubMed). In total, there are 83 published cases (61 of congenital haemophilia and 22 of acquired haemophilia).
Misdiagnosis or failure to perform early haematological treatment in PwH suffering from ACS, followed by extensive fasciotomy if haematological treatment does not stop the problem, may result in permanent disability of the affected limb. The prognosis will depend on the intensity and duration of the compartment pressure elevation. For PwH, adequate clotting factor replacement should be the first step of treatment, as it may be effective in some cases of ACS. In general, factor levels of 50%-100% should be maintained in the perioperative period; thereafter, the dose can be gradually reduced to maintain levels at 50% for approximately 2 weeks or longer if necessary.
急性骨筋膜室综合征(ACS)是一种外科急症,定义为骨筋膜室内肌内压力升高,这会损害毛细血管灌注并威胁骨筋膜室组织的存活。骨筋膜室内压力持续升高会导致神经和肌肉发生不可逆坏死,从而造成永久性损伤。
对先天性和获得性血友病患者(PwH)急性骨筋膜室综合征的诊断和治疗相关文献进行叙述性综述。
于2024年2月28日前在PubMed(MEDLINE)和Cochrane图书馆中使用“血友病和骨筋膜室综合征”作为关键词进行英文文献检索。
我们在PubMed中找到77篇文章(其中19篇因与主题并非严格相关而被排除),在Cochrane图书馆中找到1篇文章(该文章在PubMed中重复出现)。总共83例已发表病例(先天性血友病61例,获得性血友病22例)。
患有急性骨筋膜室综合征的血友病患者若误诊或未进行早期血液学治疗,若血液学治疗无法解决问题随后进行广泛的筋膜切开术,可能会导致患肢永久性残疾。预后将取决于骨筋膜室压力升高的强度和持续时间。对于血友病患者,充分的凝血因子替代治疗应是治疗的第一步,因为在某些急性骨筋膜室综合征病例中可能有效。一般来说,围手术期应维持凝血因子水平在50%-100%;此后,剂量可逐渐减少,必要时将水平维持在50%约2周或更长时间。